Finance

Lists
Why is KN0 down 6.25%?
Dive Deeper
KN0:FRA
Dicot Pharma AB
€0.014
-6.25%
(-0.00090) 1D
Sep 30, 10:00:00 PM GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for KN0...
Open
€0.01
High
€0.01
Low
€0.01
Mkt. cap
793.06M
Avg. vol.
0.00
Volume
0.00
52-wk high
€0.11
52-wk low
€0.01
No. of employees
4
Open
€0.01
High
€0.01
Low
€0.01
Mkt. cap
793.06M
Avg. vol.
0.00
Volume
0.00
52-wk high
€0.11
52-wk low
€0.01
No. of employees
4
News stories
From web sources and news partners
About Dicot Pharma AB
CEO-
Employees4
Founded2015
Headquarters-
SectorPharmaceutical industry
Websitedicotpharma.com
Previous reportsAll values in SEK
Loading Previous Earnings...
Revenue
Net income
All values in SEK
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
16.60M
17.24M
15.00M
18.40M
Operating expense
16.60M
17.32M
15.10M
18.70M
Total operating expenses
16.60M
17.32M
15.10M
18.70M
Operating income
-16.60M
-17.32M
-15.10M
-18.70M
Other non operating income
-
-99.00K
-
100.00K
EBT including unusual items
-16.10M
-16.84M
-14.80M
-18.40M
EBT excluding unusual items
-16.10M
-16.84M
-14.80M
-18.40M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
86.00K
100.00K
300.00K
Net income
-16.10M
-16.84M
-14.80M
-18.40M
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
500.00K
429.00K
300.00K
200.00K
Interest expense
-
-6.00K
-
-
Net interest expenses
500.00K
423.00K
300.00K
200.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-16.60M
-17.32M
-
-
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps